ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Income Statement Zhongzhi Pharmaceutical Holdings Limited

Equities

3737

KYG989611085

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:12 08/10/2024 pm IST			5-day change	1st Jan Change
1.020 ^HKD	-0.97%		-5.56%	-28.17%

09/09	Zhongzhi Pharmaceutical Holdings Limited Announces Resignation of Peng Zhiyun as Non-Executive Director	CI
23/08	Zhongzhi Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	CI

aeda24db3cc9705da4bd3e747c.mQnOVuIcuagrGeFRpIjhNGTTVIkFeZm5zC6xlF-DYo4._1-RDtok6N1iLsw5yLC7WwepDPxUKa3_uEWA_BHSANbdXYAX0X_NnlNdgg

Published financial data: ZHONGZHI PHARMACEUTICAL HOLDINGS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	1.34B	1.6B	1.75B	1.83B	2.05B
Total Revenues	1.34B	1.6B	1.75B	1.83B	2.05B
Cost of Goods Sold, Total	508M	613M	685M	759M	835M
Gross Profit	834M	991M	1.06B	1.07B	1.21B
Selling General & Admin Expenses, Total	648M	791M	932M	915M	995M
Other Operating Expenses	49.72M	52.3M	49.64M	49.28M	55.87M
Other Operating Expenses, Total	697M	843M	982M	964M	1.05B
Operating Income	137M	148M	79.58M	104M	164M
Interest Expense, Total	-4.01M	-5.22M	-7.08M	-6.56M	-7.87M
Interest And Investment Income	8.28M	10.08M	4.22M	4M	7.02M
Net Interest Expenses	4.27M	4.86M	-2.86M	-2.56M	-851K
Other Non Operating Income (Expenses)	6.14M	13.65M	24.6M	26.58M	40.19M
EBT, Excl. Unusual Items	147M	167M	101M	128M	203M
Gain (Loss) On Sale Of Investments	8.76M	7.81M	-39.61M	2.43M	3.89M
Gain (Loss) On Sale Of Assets	3K	-217K	106K	694K	431K
Other Unusual Items	-	-7.1M	-	-	-
EBT, Incl. Unusual Items	156M	167M	61.81M	131M	208M
Income Tax Expense	41.25M	28.6M	9.45M	23.74M	43.45M
Earnings From Continuing Operations	115M	139M	52.37M	107M	164M
Net Income to Company	115M	139M	52.37M	107M	164M
Minority Interest	-	-87K	-238K	-528K	-1.36M
Net Income - (IS)	115M	139M	52.13M	106M	163M
Net Income to Common Incl Extra Items	115M	139M	52.13M	106M	163M
Net Income to Common Excl. Extra Items	115M	139M	52.13M	106M	163M
Per Share Items
Net EPS - Basic	0.14	0.17	0.06	0.13	0.19
Basic EPS - Continuing Operations	0.14	0.17	0.06	0.13	0.19
Basic Weighted Average Shares Outstanding	833M	829M	837M	847M	847M
Net EPS - Diluted	0.14	0.17	0.06	0.13	0.19
Diluted EPS - Continuing Operations	0.14	0.17	0.06	0.13	0.19
Diluted Weighted Average Shares Outstanding	835M	829M	837M	847M	847M
Normalized Basic EPS	0.11	0.13	0.08	0.09	0.15
Normalized Diluted EPS	0.11	0.13	0.08	0.09	0.15
Dividend Per Share	0.05	0.03	-	0.05	0.08
Payout Ratio	33.22	35.35	-	-	71.35
Supplemental Items
EBITDA	166M	209M	122M	154M	215M
EBITA	137M	149M	82.86M	104M	165M
EBIT	137M	148M	79.58M	104M	164M
EBITDAR	173M	212M	126M	155M	216M
Effective Tax Rate - (Ratio)	26.45	17.1	15.28	18.17	20.93
Current Domestic Taxes	31.54M	18.85M	25.01M	20.42M	51.37M
Total Current Taxes	31.54M	18.85M	25.01M	20.42M	51.37M
Deferred Domestic Taxes	9.7M	9.75M	-	-	-
Total Deferred Taxes	9.7M	9.75M	-15.56M	3.32M	-7.92M
Normalized Net Income	91.98M	104M	63.08M	79.18M	126M
Interest on Long-Term Debt	3.93M	3.83M	4.41M	4.64M	5.25M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	126M	189M	227M	180M	206M
Selling and Marketing Expenses	563M	695M	826M	809M	887M
General and Administrative Expenses	78.07M	91.78M	103M	105M	107M
Research And Development Expense From Footnotes	47.45M	50.19M	43.83M	46.35M	49.98M
Net Rental Expense, Total	6.34M	3.78M	3.52M	737K	952K
Imputed Operating Lease Interest Expense	-	1M	1.1M	223K	347K
Imputed Operating Lease Depreciation	-	2.78M	2.42M	514K	605K
Stock-Based Comp., Other (Total)	1.64M	1.12M	-	-	-
Total Stock-Based Compensation	1.64M	1.12M	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	380M	294M	233M	381M	164M
Short Term Investments	7.86M	16.43M	15.67M	-	25.66M
Trading Asset Securities, Total	-	580K	8.8M	14.69M	2.28M
Total Cash And Short Term Investments	388M	311M	258M	396M	192M
Accounts Receivable, Total	243M	283M	294M	312M	328M
Other Receivables	3.64M	2.17M	13.88M	-	8.47M
Total Receivables	246M	285M	307M	312M	336M
Inventory	199M	247M	268M	323M	330M
Other Current Assets, Total	4.93M	40.47M	24.1M	60.76M	15.34M
Total Current Assets	839M	884M	857M	1.09B	874M
Gross Property Plant And Equipment	599M	645M	793M	860M	991M
Accumulated Depreciation	-210M	-213M	-246M	-286M	-327M
Net Property Plant And Equipment	389M	432M	547M	574M	664M
Long-term Investments	16.78M	24.81M	17M	17.91M	49.31M
Goodwill	1.63M	1.63M	1.63M	1.63M	1.63M
Other Intangibles, Total	18.56M	19.56M	18.29M	15.4M	14.22M
Deferred Tax Assets Long-Term	13.38M	16.21M	31.97M	30.19M	30.07M
Other Long-Term Assets, Total	2.74M	42.44M	50.47M	146M	159M
Total Assets	1.28B	1.42B	1.52B	1.88B	1.79B
Liabilities
Accounts Payable, Total	104M	110M	121M	190M	191M
Accrued Expenses, Total	45.07M	54.7M	59.34M	89.87M	46.66M
Short-term Borrowings	31.35M	78.92M	57.24M	36.03M	-
Current Portion of Long-Term Debt	-	-	-	-	27.33M
Current Portion of Leases	32.19M	35.77M	37.87M	40.21M	48.25M
Current Income Taxes Payable	29.71M	26.58M	27.71M	30.76M	39.58M
Unearned Revenue Current, Total	32.58M	35.53M	29.81M	135M	33.13M
Other Current Liabilities	147M	144M	168M	210M	223M
Total Current Liabilities	422M	485M	501M	731M	609M
Long-Term Debt	-	-	-	-	22.68M
Long-Term Leases	63.97M	73.22M	80.62M	94.62M	76.59M
Unearned Revenue Non Current	17.77M	14.22M	15.43M	15.84M	11.87M
Deferred Tax Liability Non Current	13.27M	25.86M	26.06M	27.59M	19.55M
Total Liabilities	517M	599M	623M	869M	739M
Common Stock, Total	6.65M	6.65M	6.85M	6.85M	6.85M
Additional Paid In Capital	243M	173M	203M	203M	86.73M
Retained Earnings	467M	606M	658M	765M	927M
Comprehensive Income and Other	45.83M	34.5M	30.9M	28.75M	27.66M
Total Common Equity	763M	820M	899M	1B	1.05B
Minority Interest	-	1.59M	2.42M	2.97M	4.82M
Total Equity	763M	822M	901M	1.01B	1.05B
Total Liabilities And Equity	1.28B	1.42B	1.52B	1.88B	1.79B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	840M	840M	864M	864M	864M
ECS Total Common Shares Outstanding	840M	840M	864M	864M	864M
Book Value / Share	0.91	0.98	1.04	1.16	1.21
Tangible Book Value	743M	799M	879M	986M	1.03B
Tangible Book Value Per Share	0.88	0.95	1.02	1.14	1.2
Total Debt	128M	188M	176M	171M	175M
Net Debt	-261M	-123M	-82.1M	-225M	-17.45M
Debt Equivalent Oper. Leases	50.74M	30.28M	28.14M	5.9M	7.62M
Minority Interest, Total (Incl. Fin. Div)	-	1.59M	2.42M	2.97M	4.82M
Equity Method Investments, Total	417K	392K	381K	416K	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	47.04M	46.78M	45.37M	56.59M	71.12M
Inventories - Work In Process, Total	6.84M	11.6M	15.15M	12.69M	19.6M
Inventories - Finished Goods, Total	145M	189M	208M	254M	239M
Buildings, Total	162M	196M	194M	268M	280M
Machinery, Total	117M	142M	181M	221M	251M
Full Time Employees	3.24K	4.19K	3.15K	2.88K	2.64K
Accumulated Allowance for Doubtful Accounts (Supple)	2.71M	3.11M	3.55M	3.39M	3.86M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	115M	139M	52.13M	106M	163M
Depreciation & Amortization - CF	61.71M	96.91M	81.77M	92.75M	98.65M
Amortization of Goodwill and Intangible Assets - (CF)	158K	638K	3.28M	833K	830K
Depreciation & Amortization, Total	61.87M	97.55M	85.05M	93.58M	99.48M
Amortization of Deferred Charges, Total - (CF)	1.66M	2.2M	-	2.8M	2.6M
(Gain) Loss From Sale Of Asset	-3K	217K	-106K	-694K	-431K
(Gain) Loss on Sale of Investments - (CF)	-8.76M	-7.51M	40.44M	-2.43M	-3.61M
Stock-Based Compensation (CF)	1.64M	1.12M	-	-	-
Provision and Write-off of Bad Debts	1.25M	394K	442K	-162K	474K
Other Operating Activities, Total	9.76M	-9.04M	-27.84M	-3.04M	-15.37M
Change In Accounts Receivable	-86.99M	-52.99M	10.03M	-13.59M	-18.22M
Change In Inventories	-20.5M	-48.2M	-21.03M	-59.79M	-10.65M
Change In Accounts Payable	18.88M	6.14M	10.39M	68.95M	1.19M
Change in Unearned Revenues	14.7M	9.51M	10.57M	10.53M	8.66M
Change in Other Net Operating Assets	59.62M	-44.74M	18.3M	82.03M	-125M
Cash from Operations	168M	93.18M	178M	285M	102M
Capital Expenditure	-57.17M	-114M	-186M	-88.41M	-169M
Sale of Property, Plant, and Equipment	421K	9.22M	2.53M	21.83M	17.1M
Cash Acquisitions	-560K	-	-	-	-
Sale (Purchase) of Intangible assets	-8.81M	-3.84M	-2.01M	-741K	-2.25M
Investment in Marketable and Equity Securities, Total	10.09M	-143M	22.7M	70.94M	-55.45M
Other Investing Activities, Total	-591K	1.58M	26.66M	9.76M	7.02M
Cash from Investing	-56.62M	-250M	-136M	13.38M	-203M
Short Term Debt Issued, Total	31.35M	78.92M	124M	10.5M	-
Long-Term Debt Issued, Total	-	-	-	-	49.67M
Total Debt Issued	31.35M	78.92M	124M	10.5M	49.67M
Short Term Debt Repaid, Total	-1.38M	-31.35M	-146M	-31.72M	-
Long-Term Debt Repaid, Total	-34.01M	-38.26M	-45.41M	-46.95M	-88.62M
Total Debt Repaid	-35.39M	-69.62M	-191M	-78.67M	-88.62M
Issuance of Common Stock	-	-	30.04M	-	-
Repurchase of Common Stock	-	-12.32M	-4.38M	-	-
Common Dividends Paid	-38.1M	-48.97M	-	-	-116M
Common & Preferred Stock Dividends Paid	-38.1M	-48.97M	-	-	-116M
Special Dividend Paid	-22.72M	-21.44M	-	-	-
Other Financing Activities, Total	-	1.5M	600K	20K	485K
Cash from Financing	-64.86M	-71.93M	-40.83M	-68.14M	-155M
Foreign Exchange Rate Adjustments	1.28M	-125K	781K	-2.18M	-769K
Net Change in Cash	47.64M	-229M	2.35M	228M	-257M
Supplemental Items
Cash Interest Paid	77K	1.39M	2.67M	1.92M	2.61M
Cash Income Tax Paid (Refund)	22.47M	21.98M	23.88M	17.37M	42.54M
Levered Free Cash Flow	63.18M	-37.9M	-49.32M	221M	-104M
Unlevered Free Cash Flow	65.69M	-34.64M	-44.89M	226M	-99.14M
Change In Net Working Capital	18.99M	110M	-8.18M	-154M	132M
Net Debt Issued / Repaid	-4.04M	9.3M	-67.09M	-68.16M	-38.96M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	7.46	6.86	3.38	3.81	5.59
Return on Total Capital	10.7	9.75	4.77	5.74	8.52
Return On Equity %	15.6	17.49	6.08	11.21	15.94
Return on Common Equity	15.6	17.5	6.07	11.19	15.87
Margin Analysis
Gross Profit Margin %	62.16	61.79	60.77	58.45	59.25
SG&A Margin	48.26	49.29	53.37	50.09	48.53
EBITDA Margin %	12.4	13.01	7	8.43	10.48
EBITA Margin %	10.2	9.28	4.74	5.71	8.04
EBIT Margin %	10.19	9.24	4.56	5.67	8
Income From Continuing Operations Margin %	8.55	8.64	3	5.86	8.01
Net Income Margin %	8.55	8.64	2.98	5.83	7.94
Net Avail. For Common Margin %	8.55	8.64	2.98	5.83	7.94
Normalized Net Income Margin	6.85	6.49	3.61	4.34	6.13
Levered Free Cash Flow Margin	4.71	-2.36	-2.82	12.13	-5.08
Unlevered Free Cash Flow Margin	4.89	-2.16	-2.57	12.35	-4.84
Asset Turnover
Asset Turnover	1.17	1.19	1.19	1.07	1.12
Fixed Assets Turnover	4.16	3.91	3.57	3.26	3.31
Receivables Turnover (Average Receivables)	6.63	6.1	6.06	6.03	6.41
Inventory Turnover (Average Inventory)	2.69	2.75	2.66	2.57	2.56
Short Term Liquidity
Current Ratio	1.99	1.82	1.71	1.49	1.44
Quick Ratio	1.5	1.23	1.13	0.97	0.87
Operating Cash Flow to Current Liabilities	0.4	0.19	0.36	0.39	0.17
Days Sales Outstanding (Average Receivables)	55.04	60	60.26	60.48	56.94
Days Outstanding Inventory (Average Inventory)	135.82	133.24	137.22	142.17	142.67
Average Days Payable Outstanding	65.58	59.46	59.77	69.69	82.49
Cash Conversion Cycle (Average Days)	125.29	133.77	137.71	132.97	117.11
Long Term Solvency
Total Debt/Equity	16.7	22.87	19.5	16.98	16.6
Total Debt / Total Capital	14.31	18.61	16.32	14.52	14.24
LT Debt/Equity	8.38	8.91	8.95	9.41	9.42
Long-Term Debt / Total Capital	7.18	7.25	7.49	8.04	8.08
Total Liabilities / Total Assets	40.39	42.15	40.87	46.36	41.24
EBIT / Interest Expense	34.13	28.4	11.24	15.79	20.83
EBITDA / Interest Expense	49.57	47.1	23.25	30.07	33.48
(EBITDA - Capex) / Interest Expense	35.31	25.25	-3	16.58	11.98
Total Debt / EBITDA	0.64	0.76	1.07	0.87	0.66
Net Debt / EBITDA	-1.31	-0.5	-0.5	-1.14	-0.07
Total Debt / (EBITDA - Capex)	0.9	1.43	-8.28	1.57	1.86
Net Debt / (EBITDA - Capex)	-1.84	-0.93	3.87	-2.07	-0.19
Growth Over Prior Year